Since endogenous OSMR expression level is significantly elevated in tumor cells that harbor EGFRvIII mutation20, we employed EGFRvIII-expressing mouse astrocytes in order to identify potential OSMR binding partners endogenously using a specific antibody to OSMR. Here, OSMR is linked to neoplasm.